1.0580
0.0000
(0.00%)
At close: January 31 at 8:00:44 AM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-13,590.0000
-1,112.0000
14,314.0000
-19,370.0000
-6,797.0000
Investing Cash Flow
--
--
--
-100.0000
539.0000
Financing Cash Flow
7,872.0000
8,979.0000
3,786.0000
27,605.0000
21,120.0000
End Cash Position
36,632.0000
50,501.0000
42,634.0000
24,534.0000
16,399.0000
Income Tax Paid Supplemental Data
26.0000
344.0000
--
--
--
Interest Paid Supplemental Data
--
--
9.0000
2.0000
--
Issuance of Capital Stock
8,242.0000
9,227.0000
4,428.0000
28,491.0000
21,150.0000
Issuance of Debt
--
--
--
646.0000
2,197.0000
Repayment of Debt
--
--
-538.0000
-108.0000
--
Free Cash Flow
-13,590.0000
-1,112.0000
14,314.0000
-19,370.0000
-6,797.0000
12/31/2020 - 6/10/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
LEXXW Lexaria Bioscience Corp.
0.3810
-20.62%
ENSCW Leisure Acquisition Corp.
0.0240
+4.35%
ICUCW SeaStar Medical Holding Corporation
0.0429
+24.35%
JSPRW Jasper Therapeutics, Inc.
0.1775
+42.00%
PBMWW Psyence Biomedical Ltd.
0.0197
-17.23%
CELUW Celularity Inc.
0.0699
+5.91%
TVGNW Tevogen Bio Holdings Inc.
0.0840
+12.30%
VCNX Vaccinex, Inc.
1.2500
-3.10%
SPRO Spero Therapeutics, Inc.
0.8566
-1.54%
NCNA NuCana plc
1.0200
-0.97%